Standard Life Aberdeen »

Fulcrum Therapeutics shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 257k 6.75

More positions owned by Standard Life Aberdeen

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Merck & Co (MRK)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)

View all positions for Standard Life Aberdeen

Top funds holding Fulcrum Therapeutics

RA Capital Management
Cowen And Company
Vanguard Group
Trv Gp Iv
Citadel Advisors
Leucadia National Corporation
Logos Global Management
Dimensional Fund Advisors
Susquehanna International
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Propel Bio Management
ADAR1 Capital Management
Simplify Asset Management
Marshall Wace

View all funds holding Fulcrum Therapeutics